BIOGEN INC. Increase (Decrease) in Accrued Liabilities
BIOGEN INC. (BIIB) reported Increase (Decrease) in Accrued Liabilities of -$243.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-04-29
- BIOGEN INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$243.20M.
- BIOGEN INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $203.80M, a 87.32% increase year-over-year.
- BIOGEN INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $286.00M, a 810.83% increase year-over-year.
- BIOGEN INC. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was -$18.20M, a 129.59% decline year-over-year.
- BIOGEN INC. increase (decrease) in accrued liabilities for fiscal 2025 was $171.10M, a 595.53% increase from fiscal 2024.
- BIOGEN INC. increase (decrease) in accrued liabilities for fiscal 2024 was $24.60M.
- BIOGEN INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$201.60M.
- BIOGEN INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$113.40M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$243.20M 10-Q · filed 2026-04-29 | -$39.40M derived: sum of 2 quarters · filed 2026-04-29 | $246.60M derived: sum of 3 quarters · filed 2026-04-29 | $228.40M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $203.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $489.80M derived: sum of 2 quarters · filed 2026-02-06 | $471.60M derived: sum of 3 quarters · filed 2026-02-06 | $171.10M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $286.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $267.80M derived: sum of 2 quarters · filed 2025-10-30 | -$32.70M 10-Q · filed 2025-10-30 | $76.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$18.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$318.70M 10-Q · filed 2025-07-31 | -$209.90M derived: sum of 3 quarters · filed 2026-04-29 | -$178.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$300.50M 10-Q · filed 2026-04-29 | -$191.70M derived: sum of 2 quarters · filed 2026-04-29 | -$160.30M derived: sum of 3 quarters · filed 2026-04-29 | -$98.80M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $108.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $140.20M derived: sum of 2 quarters · filed 2026-02-06 | $201.70M derived: sum of 3 quarters · filed 2026-02-06 | $24.60M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $31.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $92.90M derived: sum of 2 quarters · filed 2025-10-30 | -$84.20M 10-Q · filed 2025-10-30 | -$579.70M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $61.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$115.60M 10-Q · filed 2025-07-31 | -$611.10M derived: sum of 3 quarters · filed 2026-02-06 | -$190.10M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | -$177.10M 10-Q · filed 2025-05-01 | -$672.60M derived: sum of 2 quarters · filed 2026-02-06 | -$251.60M derived: sum of 3 quarters · filed 2026-02-06 | -$83.70M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$495.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$74.50M derived: sum of 2 quarters · filed 2026-02-06 | $93.40M derived: sum of 3 quarters · filed 2026-02-06 | -$201.60M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $421.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $588.90M derived: sum of 2 quarters · filed 2024-10-30 | $293.90M 10-Q · filed 2024-10-30 | -$451.80M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $167.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$127.10M 10-Q · filed 2024-08-01 | -$872.80M derived: sum of 3 quarters · filed 2025-02-12 | -$874.50M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$295.00M 10-Q · filed 2024-04-24 | -$1.04B derived: sum of 2 quarters · filed 2025-02-12 | -$1.04B derived: sum of 3 quarters · filed 2025-02-12 | $53.20M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$745.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$747.40M derived: sum of 2 quarters · filed 2025-02-12 | $348.20M derived: sum of 3 quarters · filed 2025-02-12 | -$113.40M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.09B derived: sum of 2 quarters · filed 2023-11-08 | $632.30M 10-Q · filed 2023-11-08 | $780.20M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $1.10B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $634.00M 10-Q · filed 2023-07-25 | $781.90M derived: sum of 3 quarters · filed 2024-02-14 | $727.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$461.60M 10-Q · filed 2023-04-25 | -$313.70M derived: sum of 2 quarters · filed 2024-02-14 | -$368.60M derived: sum of 3 quarters · filed 2024-02-14 | -$273.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $147.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $93.00M derived: sum of 2 quarters · filed 2024-02-14 | $188.20M derived: sum of 3 quarters · filed 2024-02-14 | -$95.40M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$54.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $40.30M derived: sum of 2 quarters · filed 2022-10-25 | -$243.30M 10-Q · filed 2022-10-25 | -$462.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $95.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$188.40M 10-Q · filed 2022-07-20 | -$407.10M derived: sum of 3 quarters · filed 2023-02-15 | $407.20M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$283.60M 10-Q · filed 2022-05-03 | -$502.30M derived: sum of 2 quarters · filed 2023-02-15 | $312.00M derived: sum of 3 quarters · filed 2023-02-15 | $218.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$218.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $595.60M derived: sum of 2 quarters · filed 2023-02-15 | $501.60M derived: sum of 3 quarters · filed 2023-02-15 | $154.20M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $814.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $720.30M derived: sum of 2 quarters · filed 2021-10-20 | $372.90M 10-Q · filed 2021-10-20 | $722.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | -$94.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | -$441.40M 10-Q · filed 2021-07-22 | -$92.10M derived: sum of 3 quarters · filed 2022-02-03 | $14.90M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$347.40M 10-Q · filed 2021-04-22 | $1.90M derived: sum of 2 quarters · filed 2022-02-03 | $108.90M derived: sum of 3 quarters · filed 2022-02-03 | $31.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $349.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $456.30M derived: sum of 2 quarters · filed 2022-02-03 | $378.60M derived: sum of 3 quarters · filed 2022-02-03 | $240.20M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $107.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $29.30M derived: sum of 2 quarters · filed 2020-10-21 | -$109.10M 10-Q · filed 2020-10-21 | $255.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$77.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | -$216.10M 10-Q · filed 2020-07-22 | $148.70M derived: sum of 3 quarters · filed 2021-02-03 | $236.10M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$138.40M 10-Q · filed 2020-04-23 | $226.40M derived: sum of 2 quarters · filed 2021-02-03 | $313.80M derived: sum of 3 quarters · filed 2021-02-03 | $448.90M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $364.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $452.20M derived: sum of 2 quarters · filed 2021-02-03 | $587.30M derived: sum of 3 quarters · filed 2021-02-03 | $465.50M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $87.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $222.50M derived: sum of 2 quarters · filed 2019-10-22 | $100.70M 10-Q · filed 2019-10-22 | $377.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $135.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $13.30M 10-Q · filed 2019-07-24 | $290.40M derived: sum of 3 quarters · filed 2020-02-06 | $238.20M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | -$121.80M 10-Q · filed 2019-04-24 | $155.30M derived: sum of 2 quarters · filed 2020-02-06 | $103.10M derived: sum of 3 quarters · filed 2020-02-06 | $335.00M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $277.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $224.90M derived: sum of 2 quarters · filed 2020-02-06 | $456.80M derived: sum of 3 quarters · filed 2020-02-06 | -$227.40M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | -$52.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $179.70M derived: sum of 2 quarters · filed 2018-10-23 | -$504.50M 10-Q · filed 2018-10-23 | $293.30M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $231.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$452.30M 10-Q · filed 2018-07-24 | $345.50M derived: sum of 3 quarters · filed 2019-02-06 | $286.40M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | -$684.20M 10-Q · filed 2018-04-24 | $113.60M derived: sum of 2 quarters · filed 2019-02-06 | $54.50M derived: sum of 3 quarters · filed 2019-02-06 | $74.80M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $797.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $738.70M derived: sum of 2 quarters · filed 2019-02-06 | $759.00M derived: sum of 3 quarters · filed 2019-02-06 | $622.30M 10-K · filed 2019-02-06 | $570.10M 10-K · filed 2017-02-02 | |||
| 2016-09-30 | -$59.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$38.80M derived: sum of 2 quarters · filed 2017-10-24 | -$175.50M 10-Q · filed 2017-10-24 | -$223.20M 10-Q · filed 2016-10-26 | $198.30M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-06-30 | $20.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$116.40M 10-Q · filed 2017-07-25 | -$162.30M 10-Q · filed 2016-07-21 | $257.40M derived: sum of 3 quarters · filed 2018-02-01 | $252.80M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-03-31 | -$136.70M 10-Q · filed 2017-04-25 | -$180.80M 10-Q · filed 2016-04-21 | $237.10M derived: sum of 2 quarters · filed 2018-02-01 | $232.50M derived: sum of 3 quarters · filed 2018-02-01 | $268.10M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2015-12-31 | $373.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $369.20M derived: sum of 2 quarters · filed 2018-02-01 | $404.80M derived: sum of 3 quarters · filed 2018-02-01 | $199.30M 10-K · filed 2018-02-01 | $74.20M 10-K · filed 2016-02-03 | |||
| 2015-09-30 | -$4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $31.00M derived: sum of 2 quarters · filed 2016-10-26 | -$174.50M 10-Q · filed 2016-10-26 | -$174.53M 10-Q · filed 2015-10-21 | $50.52M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $35.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | -$169.90M 10-Q · filed 2016-07-21 | -$169.93M 10-Q · filed 2015-07-24 | $55.12M derived: sum of 3 quarters · filed 2017-02-02 | $104.70M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | -$205.50M 10-Q · filed 2016-04-21 | -$205.47M 10-Q · filed 2015-04-24 | $19.52M derived: sum of 2 quarters · filed 2017-02-02 | $69.10M derived: sum of 3 quarters · filed 2017-02-02 | $210.17M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $225.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $274.60M derived: sum of 2 quarters · filed 2017-02-02 | $415.67M derived: sum of 3 quarters · filed 2017-02-02 | $244.30M 10-K · filed 2017-02-02 | $244.38M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $49.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $190.65M derived: sum of 2 quarters · filed 2015-10-21 | $19.28M 10-Q · filed 2015-10-21 | $192.59M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $141.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | -$30.30M 10-Q · filed 2015-07-24 | $143.01M derived: sum of 3 quarters · filed 2016-02-03 | $269.77M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | -$171.37M 10-Q · filed 2015-04-24 | $1.94M derived: sum of 2 quarters · filed 2016-02-03 | $128.70M derived: sum of 3 quarters · filed 2016-02-03 | $293.64M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $173.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $300.07M derived: sum of 2 quarters · filed 2016-02-03 | $465.01M derived: sum of 3 quarters · filed 2016-02-03 | $284.10M 10-K · filed 2016-02-03 | $284.05M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $126.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $291.70M derived: sum of 2 quarters · filed 2014-10-22 | $110.79M 10-Q · filed 2014-10-22 | $280.09M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $164.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | -$15.97M 10-Q · filed 2014-07-23 | $153.33M derived: sum of 3 quarters · filed 2015-02-04 | $205.43M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$180.91M 10-Q · filed 2014-04-23 | -$11.61M derived: sum of 2 quarters · filed 2015-02-04 | $40.49M derived: sum of 3 quarters · filed 2015-02-04 | $174.49M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $169.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $221.40M derived: sum of 2 quarters · filed 2015-02-04 | $355.40M derived: sum of 3 quarters · filed 2015-02-04 | $273.37M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $52.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $186.11M derived: sum of 2 quarters · filed 2012-10-25 | $104.08M 10-Q · filed 2012-10-25 | $194.53M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $134.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $51.97M 10-Q · filed 2012-07-24 | $142.43M derived: sum of 3 quarters · filed 2014-02-06 | $153.18M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | -$82.03M 10-Q · filed 2013-04-25 | $8.43M derived: sum of 2 quarters · filed 2014-02-06 | $19.18M derived: sum of 3 quarters · filed 2014-02-06 | $100.75M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $90.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $101.21M derived: sum of 2 quarters · filed 2014-02-06 | $182.78M derived: sum of 3 quarters · filed 2014-02-06 | $33.72M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $10.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $92.33M derived: sum of 2 quarters · filed 2012-10-25 | -$56.74M 10-Q · filed 2012-10-25 | $56.76M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $81.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | -$67.49M 10-Q · filed 2012-07-24 | $46.01M derived: sum of 3 quarters · filed 2013-02-05 | $87.12M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | -$149.06M 10-Q · filed 2012-05-01 | -$35.56M derived: sum of 2 quarters · filed 2013-02-05 | $5.54M derived: sum of 3 quarters · filed 2013-02-05 | $64.67M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $113.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $154.61M derived: sum of 2 quarters · filed 2013-02-05 | $213.73M derived: sum of 3 quarters · filed 2013-02-05 | $130.88M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $41.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $100.23M derived: sum of 2 quarters · filed 2011-10-28 | $17.38M 10-Q · filed 2011-10-28 | $6.17M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $59.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | -$23.73M 10-Q · filed 2011-07-26 | -$34.94M derived: sum of 3 quarters · filed 2012-02-03 | -$95.62M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | -$82.85M 10-Q · filed 2011-04-21 | -$94.06M derived: sum of 2 quarters · filed 2012-02-03 | -$154.75M derived: sum of 3 quarters · filed 2012-02-03 | -$11.79M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | -$11.21M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | -$71.89M derived: sum of 2 quarters · filed 2012-02-03 | $71.06M derived: sum of 3 quarters · filed 2012-02-03 | -$48.94M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | -$60.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $82.27M derived: sum of 2 quarters · filed 2010-10-26 | -$37.73M 10-Q · filed 2010-10-26 | -$40.56M 10-Q · filed 2009-10-21 | -$46.75M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $142.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | $22.95M 10-Q · filed 2010-07-20 | $13.93M derived: sum of 3 quarters · filed 2011-02-04 | $67.96M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | -$120.01M 10-Q · filed 2010-04-20 | -$129.02M derived: sum of 2 quarters · filed 2011-02-04 | -$75.00M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $45.01M derived: sum of 2 quarters · filed 2011-02-04 | $146.42M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | $54.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $155.44M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | $101.41M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | $30.58M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |